|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-10-3
|
|
pubmed:abstractText |
We have previously shown electro-mechanical recto-anal alterations in irritable bowel syndrome patients (Awad R. Neurogastroenterol Motil 1993; 5; 265-271). To assess whether the alpha 2-agonist lidamidine HCL is able to modify these physiological alterations and alleviate clinical symptoms, 50 patients with irritable bowel syndrome were studied in a random, double blind, placebo-controlled trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-9033
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
169-75
|
|
pubmed:dateRevised |
2006-12-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10975022-Adrenergic beta-Agonists,
pubmed-meshheading:10975022-Adult,
pubmed-meshheading:10975022-Antidiarrheals,
pubmed-meshheading:10975022-Colonic Diseases, Functional,
pubmed-meshheading:10975022-Double-Blind Method,
pubmed-meshheading:10975022-Electromyography,
pubmed-meshheading:10975022-Gastrointestinal Motility,
pubmed-meshheading:10975022-Humans,
pubmed-meshheading:10975022-Manometry,
pubmed-meshheading:10975022-Phenylurea Compounds,
pubmed-meshheading:10975022-Rectum,
pubmed-meshheading:10975022-Reflex,
pubmed-meshheading:10975022-Sensory Thresholds
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A randomised double-blind placebo-controlled trial of lidamidine HCL in irritable bowel syndrome.
|
|
pubmed:affiliation |
Experimental Medicine and Motility Unit U-404-B, Ministry of Heath, Mexico City, Mexico. awadrichard@iserve.net.mx
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
